28 October 2015
INTELLECTUAL PROPERTY: WHO-WIPO-WTO JOINT SYMPOSIUM 2015
Public Health, Intellectual Property, and TRIPS at 20: Innovation and Access to Medicines; Learning from the Past, Illuminating the Future
At the historic juncture of the 20th anniversary of the WTO and of the TRIPS Agreement, the fifth trilateral symposium reviewed the information base on access and innovation in medical technologies and looked at possibilities and limitations for better integrating data in support of policy makers' future work. The aim was to contribute to assisting governments and other interested parties in well-informed, evidence-based policy making.
> Other WHO-WIPO-WTO joint technical symposiums
The symposium provided an opportunity to discuss practical ways in which the twin challenges of innovation and access have been addressed. It also reviewed selected data on the complex relationship between trade in medical technologies, patents, innovation and access, including the role of TRIPS flexibilities and recent experience with the use of compulsory licenses and voluntary license agreements. For more details see briefing note here.
The symposium took place back to back with a WHO-WIPO-WTO technical workshop on patentability criteria that was held at the WTO on 27 October 2015.
PROGRAMME (download as a PDF)
28 October, 9.30-10.00
Hans Rosling, Professor of International Health, Karolinska Institute; Chairman, Gapminder Foundation
28 October, 10.00-10.45
Panel 1: Ongoing Health Challenges and Policy Responses: What Does the Data Say?
Moderator: Peter Beyer, Senior Advisor, Public Health, Innovation and Intellectual Property Unit, WHO
28 October, 11.45-12.30
Panel 2: Twin Challenges of Innovation and Access: Leveraging IP to Achieve Both
Moderator: Anatole Krattiger, Director, Global Challenges Division, WIPO
28 October, 14.30-15.45
Panel 3: Trade Agreements: How to Measure Their Impact on Innovation and Access to Medicines
28 October, 16.15-17.15